Ciphergen s Revenues Rise in Q4; Net Loss Remains Flat

Feb 17, 2004

NEW YORK, Feb. 17 (GenomeWeb News) - Ciphergen Biosystems today reported increased revenues, along with stable losses and R&D expenses, for the last quarter of 2003.

Revenues for the quarter were $15.2 million, up from $13.6 million during the same period in 2002.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

WHO Panel Announced

The World Health Organization has announced the members of its gene-editing committee, according to NPR.

Research Reproducibility Scores

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Tests for All Diagnosed

The American Society of Breast Surgeons recommends all women diagnosed with breast cancer be offered genetic testing, the Washington Post says.

This Week in Science

In Science this week: comparison of modern, historical rabbit exomes uncovers parallel evolution after myxoma virus exposure; and more.

Main menu